LaSalle Street Capital Management’s AbbVie ABBV Stock Holding History

LaSalle Street Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$278K	Hold	3,665	–	–	0.32%	74
2019 Q2	$267K	Hold	3,665	–	–	0.31%	77
2019 Q1	$295K	Hold	3,665	–	–	0.35%	72
2018 Q4	$338K	Hold	3,665	–	–	0.49%	67
2018 Q3	$347K	Sell	3,665 -5,244	-59%	-$497K	0.41%	75
2018 Q2	$825K	Sell	8,909 -2,139	-19%	-$209K	0.82%	51
2018 Q1	$1.05M	Sell	11,048 -1,052	-9%	-$116K	0.83%	45
2017 Q4	$1.17M	Hold	12,100	–	–	0.81%	40
2017 Q3	$1.07M	Hold	12,100	–	–	0.79%	43
2017 Q2	$877K	Hold	12,100	–	–	0.72%	46
2017 Q1	$788K	Hold	12,100	–	–	0.66%	49
2016 Q4	$758K	Hold	12,100	–	–	0.67%	48
2016 Q3	$763K	Hold	12,100	–	–	0.71%	46
2016 Q2	$749K	Hold	12,100	–	–	0.72%	46
2016 Q1	$691K	Hold	12,100	–	–	0.68%	47
2015 Q4	$717K	Hold	12,100	–	–	0.71%	45
2015 Q3	$658K	Hold	12,100	–	–	0.7%	47
2015 Q2	$813K	Hold	12,100	–	–	0.79%	45
2015 Q1	$708K	Hold	12,100	–	–	0.7%	50
2014 Q4	$792K	Buy	+12,100	New	+$763K	0.77%	45

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LaSalle Street Capital Management's ABBV Position: Q3 2019 in Review

LaSalle Street Capital Management held its AbbVie (ABBV) position steady in Q3 2019 at 3,665 shares worth $278K. The position accounts for 0.32% of the portfolio, ranked #74.

LaSalle Street Capital Management first reported a position in ABBV in Q4 2014 and has held it in 20 quarters since. The position peaked at $1.17M in Q4 2017. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

LaSalle Street Capital Management held 3,665 shares of AbbVie worth $278K as of Q3 2019.
LaSalle Street Capital Management left its AbbVie share count unchanged in Q3 2019.
AbbVie made up 0.32% of LaSalle Street Capital Management's portfolio in Q3 2019, its #74 holding.
LaSalle Street Capital Management first reported a position in AbbVie in Q4 2014 and has held it in 20 quarters since.
LaSalle Street Capital Management's AbbVie position peaked at $1.17M in Q4 2017.
2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on LaSalle Street Capital Management's 13F filing for Q3 2019, filed 28 Oct 2019.